A 52-year-old man with a 10-year history of type 2 diabetes mellitus presents with recurrent hypoglycemic episodes despite taking metformin and a sulfonylurea. His fasting blood glucose is 95 mg/dL, but he reports episodes of tremor, diaphoresis, and confusion occurring 2–3 hours after meals. C-peptide level is 4.2 ng/mL (normal fasting: 0.8–3.1 ng/mL). Insulin level is 18 mIU/mL (normal fasting: 2–12 mIU/mL). Which of the following best explains the mechanism of his hypoglycemia?

Explanation

## Mechanism of Sulfonylurea-Induced Hypoglycemia ### Clinical Interpretation of Biochemistry **Key Point:** Elevated fasting C-peptide (4.2 ng/mL) and insulin (18 mIU/mL) in the setting of hypoglycemia indicate **endogenous hyperinsulinism** — the patient's own beta cells are secreting excessive insulin. ### Why C-Peptide and Insulin Are Both Elevated | Marker | Interpretation | |--------|----------------| | **C-peptide 4.2 ng/mL** | Endogenous insulin secretion is high (normal fasting ≤3.1) | | **Insulin 18 mIU/mL** | Circulating insulin is elevated (normal fasting ≤12) | | **Both elevated together** | Rules out exogenous insulin; confirms beta cell overactivity | | **Fasting glucose 95 mg/dL** | Hypoglycemia is *reactive* (postprandial), not fasting | ### Pathophysiology of Sulfonylurea-Induced Hypoglycemia 1. **Sulfonylureas** (e.g., glibenclamide) close ATP-sensitive K⁺ channels on beta cells 2. **Membrane depolarization** → Ca²⁺ influx → constitutive insulin secretion 3. **Insulin secretion becomes glucose-independent** — continues even as glucose falls 4. **Loss of physiologic feedback** — normal suppression of insulin at low glucose is bypassed 5. **Severe hypoglycemia** → Tremor, diaphoresis, confusion (adrenergic symptoms) **High-Yield:** Sulfonylureas cause hypoglycemia because they **force insulin secretion regardless of blood glucose level**. This is why they carry a black-box warning for hypoglycemia, especially in elderly patients and those with renal/hepatic impairment. ### Why Glucagon Response Is Intact Here The patient's hypoglycemic symptoms (tremor, diaphoresis) indicate an **adrenergic response**, which means glucagon secretion is occurring — but it is **overwhelmed by the excessive insulin**. The insulin:glucagon ratio is pathologically high. **Clinical Pearl:** Postprandial hypoglycemia 2–3 hours after meals is classic for sulfonylurea excess. The drug causes a surge of insulin that outlasts the meal's glucose absorption. ### Distinction from Other Causes - ~~Impaired glucagon response~~ — Glucagon *is* being secreted (evidenced by adrenergic symptoms); the problem is excessive insulin, not glucagon deficiency - ~~Metformin-induced hypoglycemia~~ — Metformin does not cause hypoglycemia when used alone; it improves insulin sensitivity but does not force insulin secretion - ~~Reduced hepatic glycogenolysis~~ — Chronic hyperglycemia does not impair glycogenolysis; the problem here is excessive insulin suppressing hepatic glucose output [cite:KD Tripathi 8e Ch 12; Harrison 21e Ch 397]